Markets:

Overview

News

Currencies

International

Treasuries

Clarivate Plc Ordinary Shares (NY:CLVT)

1.915 -0.155 (-7.49%)

Streaming Delayed Price Updated: 1:09 PM EDT, Sep 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Clarivate Plc Ordinary Shares

< Previous 1 2 3 4 5 Next >

12 Industrials Stocks Moving In Tuesday's Pre-Market Session ↗

April 29, 2025

Via Benzinga

Earnings Scheduled For April 29, 2025 ↗

April 29, 2025

Via Benzinga

Earnings Scheduled For February 19, 2025 ↗

February 19, 2025

Via Benzinga

Bargains Galore? 3 Stocks With Insider Buying in the Millions

December 10, 2024

Clarivate, Prospect Capital, and Nine Energy Service insiders bought millions in stock. See what’s driving this insider confidence.

Via MarketBeat

Topics Artificial Intelligence

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗

November 25, 2024

Via Benzinga

Critical Insights From Clarivate Analyst Ratings: What You Need To Know ↗

May 09, 2024

Via Benzinga

The Analyst Landscape: 5 Takes On Clarivate ↗

February 28, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Israel, Lebanon Reach Reported Cease-Fire Deal: Gold, Oil Tumble; S&P 500, Dow Jointly Hit Record Highs ↗

November 25, 2024

Israel and Lebanon agree on framework for cease-fire deal to end over a year of conflict, Axios reports. Global markets react with gold and oil prices falling.

Via Benzinga

Topics Stocks

12 Industrials Stocks Moving In Wednesday's Intraday Session ↗

November 06, 2024

Via Benzinga

Clarivate Partners With Libraries To Unveil AI Research Assistant, Boosting Academic Integrity And Discovery ↗

September 18, 2024

Clarivate launched Primo Research Assistant, which is a new generative AI-powered library discovery solution. Primo Research Assistant, part of the Primo Discovery solution, uses a Retrieval Augmented...

Via Benzinga

Topics Artificial Intelligence

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday ↗

August 13, 2024

Via Benzinga

Preview: Clarivate's Earnings ↗

February 26, 2024

Via Benzinga

The Latest Analyst Ratings for Clarivate ↗

September 26, 2023

Via Benzinga

CLVT Stock Earnings: Clarivate Beats EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

CLVT stock results show that Clarivate beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio? ↗

July 21, 2024

Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%).

Via Benzinga

Why Is Clarivate Stock Trading Higher Premarket Monday? ↗

May 20, 2024

Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connecting users to trademark data in 258 countries and territories. Solution...

Via Benzinga

Topics Artificial Intelligence

CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

CLVT stock results show that Clarivate met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Analytics Firm Clarivate Acquires AI Start-Up MotionHall - What's On The Cards? ↗

March 21, 2024

Clarivate has agreed to acquire the majority of assets of MotionHall, a Silicon Valley technology start-up. MotionHall serves life sciences with vertical artificial intelligence (AI) solutions. The...

Via Benzinga

Topics Artificial Intelligence

Exor Amplifies Stake In Clarivate, Proposes New Board Member ↗

March 04, 2024

Exor N.V. increases stake in Clarivate Plc to 10.1%, with potential to reach 17.5%. Suzanne Heywood to join board, showing strong support for Clarivate's growth and mission.

Via Benzinga

S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday? ↗

February 27, 2024

On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations.

Via Benzinga

Topics Stocks

12 Industrials Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

12 Industrials Stocks Moving In Tuesday's Pre-Market Session ↗

February 27, 2024

Via Benzinga

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

12 Industrials Stocks Moving In Tuesday's Pre-Market Session ↗

November 07, 2023

Via Benzinga

12 Industrials Stocks Moving In Tuesday's After-Market Session ↗

October 17, 2023

Via Benzinga

12 Industrials Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

Clarivate Buys Alethea, Creates Academia And Government Innovation Incubator ↗

September 26, 2023

Clarivate PLC (NYSE: CLVT) disclosed the plan to create an Academia and Government Innovation Incubator to

Via Benzinga

Clarivate Launches AI-Powered Tool For IP Forecasts And Budgets ↗

September 20, 2023

Clarivate Plc (NYSE: CLVT) has launched Forecast, the next-generation artificial intelligence (AI)-driven solution designed to enable intellectual property (IP) professionals to efficiently

Via Benzinga

Topics Artificial Intelligence Intellectual Property

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? ↗

September 15, 2023

Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.

Via Investor's Business Daily

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.